Global Cancer Insurance Market research

Cancer Insurance Comprehensive Study by Type (Lung Cancer, Liver Cancer), Application (Children, Adult) Players and Region - Global Market Outlook to 2030

Cancer Insurance Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cancer Insurance
Cancer a type medical disease that is one of major reason for increasing death rate cross the globe. Nevertheless medical advancements have increased the chances of early detection and successful treatment, these treatments are very costly. Cancer policies can be help at this moment. Cancer insurance policy covers all stages of cancer right from the early stages to the advanced ones and this policy also defines types of the cancers to be insured. Policy holder can claim this policy only as per the benefits mentioned in that and this process is comparatively simple. Regular health insurance reimburses only hospitalization costs, the cancer policy payout can be used to meet any related cancer therapy expenses.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cancer Insurance market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

China Life Insurance (China), PingAn (China), Aviva (United Kingdom), Legal & General (United Kingdom), AXA (France), Prudential Financial (United States), Aegon (Netherlands), Allianz (Germany), AIG (United States), UnitedHealthcare (United States) and Zurich insurance (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are MetLife (United States), Dai-ichi Mutual Life Insurance (Japan) and Sun Life Financial (Canada).

Segmentation Overview
AMA Research has segmented the market of Global Cancer Insurance market by Type (Lung Cancer and Liver Cancer), Application (Children and Adult) and Region.



On the basis of geography, the market of Cancer Insurance has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing transparency in terms of insurance and Integrating solutions through data analytics and modeling techniques

Market Growth Drivers:
Health security standards advancement, Rising chronic diseases like cancer among population and Increasing medical care expenses

Challenges:
competitive market and high threat of new entrant

Restraints:
Undulating economic conditions and comparatively less profit margins

Opportunities:
Digitization in accessing policies and Improving disposable income

Market Leaders and their expansionary development strategies
In March 2023, Seagen Inc. is finally being acquired — by Pfizer Inc. The USD43 billion proposed deal should quell investor calls for Pfizer to do something splashier with its Covid cash, and could put Pfizer into a leadership position in oncology. But Pfizer still has a lot of work to do to convince investors that its huge bet on Seagen is sound.
In August 2023,Swiss Re has partnered with composite insurer, Income Insurance Limited (Income Insurance), on a first-in-market cancer insurance product that offers a guaranteed post-cancer term option and support throughout the journey from diagnosis to recovery.


Key Target Audience
Health maintenance organization, Technology, equipment, and solution providers, Private utility players, Government and research organizations, Distribution consultancies and End users ( public and private sectors)

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Lung Cancer
  • Liver Cancer
By Application
  • Children
  • Adult
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Health security standards advancement
      • 3.2.2. Rising chronic diseases like cancer among population
      • 3.2.3. Increasing medical care expenses
    • 3.3. Market Challenges
      • 3.3.1. Competitive market
      • 3.3.2. High threat of new entrant
    • 3.4. Market Trends
      • 3.4.1. Increasing transparency in terms of insurance
      • 3.4.2. Integrating solutions through data analytics and modeling techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cancer Insurance, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Cancer Insurance (Value)
      • 5.2.1. Global Cancer Insurance by: Type (Value)
        • 5.2.1.1. Lung Cancer
        • 5.2.1.2. Liver Cancer
      • 5.2.2. Global Cancer Insurance by: Application (Value)
        • 5.2.2.1. Children
        • 5.2.2.2. Adult
      • 5.2.3. Global Cancer Insurance Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Cancer Insurance: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. China Life Insurance (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PingAn (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aviva (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Legal & General (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AXA (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Prudential Financial (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Aegon (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Allianz (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AIG (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. UnitedHealthcare (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Zurich insurance (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Cancer Insurance Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Cancer Insurance (Value)
      • 7.2.1. Global Cancer Insurance by: Type (Value)
        • 7.2.1.1. Lung Cancer
        • 7.2.1.2. Liver Cancer
      • 7.2.2. Global Cancer Insurance by: Application (Value)
        • 7.2.2.1. Children
        • 7.2.2.2. Adult
      • 7.2.3. Global Cancer Insurance Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cancer Insurance: by Type(USD Million)
  • Table 2. Cancer Insurance Lung Cancer , by Region USD Million (2018-2023)
  • Table 3. Cancer Insurance Liver Cancer , by Region USD Million (2018-2023)
  • Table 4. Cancer Insurance: by Application(USD Million)
  • Table 5. Cancer Insurance Children , by Region USD Million (2018-2023)
  • Table 6. Cancer Insurance Adult , by Region USD Million (2018-2023)
  • Table 7. South America Cancer Insurance, by Country USD Million (2018-2023)
  • Table 8. South America Cancer Insurance, by Type USD Million (2018-2023)
  • Table 9. South America Cancer Insurance, by Application USD Million (2018-2023)
  • Table 10. Brazil Cancer Insurance, by Type USD Million (2018-2023)
  • Table 11. Brazil Cancer Insurance, by Application USD Million (2018-2023)
  • Table 12. Argentina Cancer Insurance, by Type USD Million (2018-2023)
  • Table 13. Argentina Cancer Insurance, by Application USD Million (2018-2023)
  • Table 14. Rest of South America Cancer Insurance, by Type USD Million (2018-2023)
  • Table 15. Rest of South America Cancer Insurance, by Application USD Million (2018-2023)
  • Table 16. Asia Pacific Cancer Insurance, by Country USD Million (2018-2023)
  • Table 17. Asia Pacific Cancer Insurance, by Type USD Million (2018-2023)
  • Table 18. Asia Pacific Cancer Insurance, by Application USD Million (2018-2023)
  • Table 19. China Cancer Insurance, by Type USD Million (2018-2023)
  • Table 20. China Cancer Insurance, by Application USD Million (2018-2023)
  • Table 21. Japan Cancer Insurance, by Type USD Million (2018-2023)
  • Table 22. Japan Cancer Insurance, by Application USD Million (2018-2023)
  • Table 23. India Cancer Insurance, by Type USD Million (2018-2023)
  • Table 24. India Cancer Insurance, by Application USD Million (2018-2023)
  • Table 25. South Korea Cancer Insurance, by Type USD Million (2018-2023)
  • Table 26. South Korea Cancer Insurance, by Application USD Million (2018-2023)
  • Table 27. Taiwan Cancer Insurance, by Type USD Million (2018-2023)
  • Table 28. Taiwan Cancer Insurance, by Application USD Million (2018-2023)
  • Table 29. Australia Cancer Insurance, by Type USD Million (2018-2023)
  • Table 30. Australia Cancer Insurance, by Application USD Million (2018-2023)
  • Table 31. Rest of Asia-Pacific Cancer Insurance, by Type USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Cancer Insurance, by Application USD Million (2018-2023)
  • Table 33. Europe Cancer Insurance, by Country USD Million (2018-2023)
  • Table 34. Europe Cancer Insurance, by Type USD Million (2018-2023)
  • Table 35. Europe Cancer Insurance, by Application USD Million (2018-2023)
  • Table 36. Germany Cancer Insurance, by Type USD Million (2018-2023)
  • Table 37. Germany Cancer Insurance, by Application USD Million (2018-2023)
  • Table 38. France Cancer Insurance, by Type USD Million (2018-2023)
  • Table 39. France Cancer Insurance, by Application USD Million (2018-2023)
  • Table 40. Italy Cancer Insurance, by Type USD Million (2018-2023)
  • Table 41. Italy Cancer Insurance, by Application USD Million (2018-2023)
  • Table 42. United Kingdom Cancer Insurance, by Type USD Million (2018-2023)
  • Table 43. United Kingdom Cancer Insurance, by Application USD Million (2018-2023)
  • Table 44. Netherlands Cancer Insurance, by Type USD Million (2018-2023)
  • Table 45. Netherlands Cancer Insurance, by Application USD Million (2018-2023)
  • Table 46. Rest of Europe Cancer Insurance, by Type USD Million (2018-2023)
  • Table 47. Rest of Europe Cancer Insurance, by Application USD Million (2018-2023)
  • Table 48. MEA Cancer Insurance, by Country USD Million (2018-2023)
  • Table 49. MEA Cancer Insurance, by Type USD Million (2018-2023)
  • Table 50. MEA Cancer Insurance, by Application USD Million (2018-2023)
  • Table 51. Middle East Cancer Insurance, by Type USD Million (2018-2023)
  • Table 52. Middle East Cancer Insurance, by Application USD Million (2018-2023)
  • Table 53. Africa Cancer Insurance, by Type USD Million (2018-2023)
  • Table 54. Africa Cancer Insurance, by Application USD Million (2018-2023)
  • Table 55. North America Cancer Insurance, by Country USD Million (2018-2023)
  • Table 56. North America Cancer Insurance, by Type USD Million (2018-2023)
  • Table 57. North America Cancer Insurance, by Application USD Million (2018-2023)
  • Table 58. United States Cancer Insurance, by Type USD Million (2018-2023)
  • Table 59. United States Cancer Insurance, by Application USD Million (2018-2023)
  • Table 60. Canada Cancer Insurance, by Type USD Million (2018-2023)
  • Table 61. Canada Cancer Insurance, by Application USD Million (2018-2023)
  • Table 62. Mexico Cancer Insurance, by Type USD Million (2018-2023)
  • Table 63. Mexico Cancer Insurance, by Application USD Million (2018-2023)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Cancer Insurance: by Type(USD Million)
  • Table 76. Cancer Insurance Lung Cancer , by Region USD Million (2025-2030)
  • Table 77. Cancer Insurance Liver Cancer , by Region USD Million (2025-2030)
  • Table 78. Cancer Insurance: by Application(USD Million)
  • Table 79. Cancer Insurance Children , by Region USD Million (2025-2030)
  • Table 80. Cancer Insurance Adult , by Region USD Million (2025-2030)
  • Table 81. South America Cancer Insurance, by Country USD Million (2025-2030)
  • Table 82. South America Cancer Insurance, by Type USD Million (2025-2030)
  • Table 83. South America Cancer Insurance, by Application USD Million (2025-2030)
  • Table 84. Brazil Cancer Insurance, by Type USD Million (2025-2030)
  • Table 85. Brazil Cancer Insurance, by Application USD Million (2025-2030)
  • Table 86. Argentina Cancer Insurance, by Type USD Million (2025-2030)
  • Table 87. Argentina Cancer Insurance, by Application USD Million (2025-2030)
  • Table 88. Rest of South America Cancer Insurance, by Type USD Million (2025-2030)
  • Table 89. Rest of South America Cancer Insurance, by Application USD Million (2025-2030)
  • Table 90. Asia Pacific Cancer Insurance, by Country USD Million (2025-2030)
  • Table 91. Asia Pacific Cancer Insurance, by Type USD Million (2025-2030)
  • Table 92. Asia Pacific Cancer Insurance, by Application USD Million (2025-2030)
  • Table 93. China Cancer Insurance, by Type USD Million (2025-2030)
  • Table 94. China Cancer Insurance, by Application USD Million (2025-2030)
  • Table 95. Japan Cancer Insurance, by Type USD Million (2025-2030)
  • Table 96. Japan Cancer Insurance, by Application USD Million (2025-2030)
  • Table 97. India Cancer Insurance, by Type USD Million (2025-2030)
  • Table 98. India Cancer Insurance, by Application USD Million (2025-2030)
  • Table 99. South Korea Cancer Insurance, by Type USD Million (2025-2030)
  • Table 100. South Korea Cancer Insurance, by Application USD Million (2025-2030)
  • Table 101. Taiwan Cancer Insurance, by Type USD Million (2025-2030)
  • Table 102. Taiwan Cancer Insurance, by Application USD Million (2025-2030)
  • Table 103. Australia Cancer Insurance, by Type USD Million (2025-2030)
  • Table 104. Australia Cancer Insurance, by Application USD Million (2025-2030)
  • Table 105. Rest of Asia-Pacific Cancer Insurance, by Type USD Million (2025-2030)
  • Table 106. Rest of Asia-Pacific Cancer Insurance, by Application USD Million (2025-2030)
  • Table 107. Europe Cancer Insurance, by Country USD Million (2025-2030)
  • Table 108. Europe Cancer Insurance, by Type USD Million (2025-2030)
  • Table 109. Europe Cancer Insurance, by Application USD Million (2025-2030)
  • Table 110. Germany Cancer Insurance, by Type USD Million (2025-2030)
  • Table 111. Germany Cancer Insurance, by Application USD Million (2025-2030)
  • Table 112. France Cancer Insurance, by Type USD Million (2025-2030)
  • Table 113. France Cancer Insurance, by Application USD Million (2025-2030)
  • Table 114. Italy Cancer Insurance, by Type USD Million (2025-2030)
  • Table 115. Italy Cancer Insurance, by Application USD Million (2025-2030)
  • Table 116. United Kingdom Cancer Insurance, by Type USD Million (2025-2030)
  • Table 117. United Kingdom Cancer Insurance, by Application USD Million (2025-2030)
  • Table 118. Netherlands Cancer Insurance, by Type USD Million (2025-2030)
  • Table 119. Netherlands Cancer Insurance, by Application USD Million (2025-2030)
  • Table 120. Rest of Europe Cancer Insurance, by Type USD Million (2025-2030)
  • Table 121. Rest of Europe Cancer Insurance, by Application USD Million (2025-2030)
  • Table 122. MEA Cancer Insurance, by Country USD Million (2025-2030)
  • Table 123. MEA Cancer Insurance, by Type USD Million (2025-2030)
  • Table 124. MEA Cancer Insurance, by Application USD Million (2025-2030)
  • Table 125. Middle East Cancer Insurance, by Type USD Million (2025-2030)
  • Table 126. Middle East Cancer Insurance, by Application USD Million (2025-2030)
  • Table 127. Africa Cancer Insurance, by Type USD Million (2025-2030)
  • Table 128. Africa Cancer Insurance, by Application USD Million (2025-2030)
  • Table 129. North America Cancer Insurance, by Country USD Million (2025-2030)
  • Table 130. North America Cancer Insurance, by Type USD Million (2025-2030)
  • Table 131. North America Cancer Insurance, by Application USD Million (2025-2030)
  • Table 132. United States Cancer Insurance, by Type USD Million (2025-2030)
  • Table 133. United States Cancer Insurance, by Application USD Million (2025-2030)
  • Table 134. Canada Cancer Insurance, by Type USD Million (2025-2030)
  • Table 135. Canada Cancer Insurance, by Application USD Million (2025-2030)
  • Table 136. Mexico Cancer Insurance, by Type USD Million (2025-2030)
  • Table 137. Mexico Cancer Insurance, by Application USD Million (2025-2030)
  • Table 138. Research Programs/Design for This Report
  • Table 139. Key Data Information from Secondary Sources
  • Table 140. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cancer Insurance: by Type USD Million (2018-2023)
  • Figure 5. Global Cancer Insurance: by Application USD Million (2018-2023)
  • Figure 6. South America Cancer Insurance Share (%), by Country
  • Figure 7. Asia Pacific Cancer Insurance Share (%), by Country
  • Figure 8. Europe Cancer Insurance Share (%), by Country
  • Figure 9. MEA Cancer Insurance Share (%), by Country
  • Figure 10. North America Cancer Insurance Share (%), by Country
  • Figure 11. Global Cancer Insurance share by Players 2023 (%)
  • Figure 12. Global Cancer Insurance share by Players (Top 3) 2023(%)
  • Figure 13. Global Cancer Insurance share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. China Life Insurance (China) Revenue, Net Income and Gross profit
  • Figure 16. China Life Insurance (China) Revenue: by Geography 2023
  • Figure 17. PingAn (China) Revenue, Net Income and Gross profit
  • Figure 18. PingAn (China) Revenue: by Geography 2023
  • Figure 19. Aviva (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Aviva (United Kingdom) Revenue: by Geography 2023
  • Figure 21. Legal & General (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Legal & General (United Kingdom) Revenue: by Geography 2023
  • Figure 23. AXA (France) Revenue, Net Income and Gross profit
  • Figure 24. AXA (France) Revenue: by Geography 2023
  • Figure 25. Prudential Financial (United States) Revenue, Net Income and Gross profit
  • Figure 26. Prudential Financial (United States) Revenue: by Geography 2023
  • Figure 27. Aegon (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Aegon (Netherlands) Revenue: by Geography 2023
  • Figure 29. Allianz (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Allianz (Germany) Revenue: by Geography 2023
  • Figure 31. AIG (United States) Revenue, Net Income and Gross profit
  • Figure 32. AIG (United States) Revenue: by Geography 2023
  • Figure 33. UnitedHealthcare (United States) Revenue, Net Income and Gross profit
  • Figure 34. UnitedHealthcare (United States) Revenue: by Geography 2023
  • Figure 35. Zurich insurance (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Zurich insurance (Switzerland) Revenue: by Geography 2023
  • Figure 37. Global Cancer Insurance: by Type USD Million (2025-2030)
  • Figure 38. Global Cancer Insurance: by Application USD Million (2025-2030)
  • Figure 39. South America Cancer Insurance Share (%), by Country
  • Figure 40. Asia Pacific Cancer Insurance Share (%), by Country
  • Figure 41. Europe Cancer Insurance Share (%), by Country
  • Figure 42. MEA Cancer Insurance Share (%), by Country
  • Figure 43. North America Cancer Insurance Share (%), by Country
List of companies from research coverage that are profiled in the study
  • China Life Insurance (China)
  • PingAn (China)
  • Aviva (United Kingdom)
  • Legal & General (United Kingdom)
  • AXA (France)
  • Prudential Financial (United States)
  • Aegon (Netherlands)
  • Allianz (Germany)
  • AIG (United States)
  • UnitedHealthcare (United States)
  • Zurich insurance (Switzerland)
Additional players considered in the study are as follows:
MetLife (United States) , Dai-ichi Mutual Life Insurance (Japan) , Sun Life Financial (Canada)
Select User Access Type

Key Highlights of Report


Mar 2024 201 Pages 88 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cancer Insurance Market research Quantitative research analysis
Global Cancer Insurance Market research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as China Life Insurance (China), PingAn (China), Aviva (United Kingdom), Legal & General (United Kingdom), AXA (France), Prudential Financial (United States), Aegon (Netherlands), Allianz (Germany), AIG (United States), UnitedHealthcare (United States) and Zurich insurance (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing transparency in terms of insurance " is seen as one of major influencing trends for Cancer Insurance Market during projected period 2023-2030.
The Cancer Insurance market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Cancer Insurance Market research Report?

Have a Query? Click Here

Other Related Reports

Skin Diagnosis System Comprehensive Study by Type (Analysis System, Skin Imaging, Skin Biopsy, Others), Application (Hospital, Beauty Salon, SPA, Dermatology Clinic, Research and Institute, Others), ...
$ 3800
Patient Data Management Systems Comprehensive Study by Type (Single Function System, Multifunction System), Application (NICU, PICU, General Ward, Other) Players and Region - Global Market Outlook to...
$ 3500
Blood Testing Comprehensive Study by Type (Instruments, Reagents and Testing Kits, Others), Application (Laboratory, Hospitals, Point of Care (POC) Testing, Blood Banks, Others), Test Types (Complete...
$ 3750
Medicine Automated Dispensing Cabinet Comprehensive Study by Type (Centralized automated dispensing cabinets, Decentralized automated dispensing cabinets), Application (Hospital, Retail pharmacies, C...
$ 3450
Scar Dressings Comprehensive Study by Type (Non-Sterile Dressings, Sterile Dressings), Product (Topical Products (Creams, Gels, Silicon Sheets, Others), Laser Products (CO2 Laser, Pulse-dyed Laser, O...
$ 3650
mHealth Services Comprehensive Study by Type (Wellness Service, Prevention, Monitoring Service, Diagnostic Service, Treatment, Information and reference), Application (General Healthcare and Fitness,...
$ 3750